ALC vs. EW: Which Stock Is the Better Value Option?

Core Insights - Alcon (ALC) is currently rated 2 (Buy) by Zacks, indicating a stronger earnings outlook compared to Edwards Lifesciences (EW), which is rated 3 (Hold) [1] - ALC is considered a better value opportunity based on its valuation metrics and earnings outlook [3] Valuation Metrics - ALC has a forward P/E ratio of 26.38, while EW has a higher forward P/E of 30.73 [2] - ALC's PEG ratio is 2.06, compared to EW's PEG ratio of 3.58, suggesting ALC is more favorably valued in terms of expected earnings growth [2] - ALC's P/B ratio stands at 1.92, significantly lower than EW's P/B ratio of 7.14, indicating ALC's market value is more aligned with its book value [3] Value Grades - ALC has a Value grade of B, while EW has a Value grade of D, further supporting the conclusion that ALC is the superior value option at this time [3]